These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3870249)

  • 21. Renal prostaglandins in cirrhosis of the liver.
    Guarner C; Colina I; Guarner F; Corzo J; Prieto J; Vilardell F
    Clin Sci (Lond); 1986 May; 70(5):477-84. PubMed ID: 3516533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bartter's syndrome with normal chloride reabsorption during indomethacin treatment.
    Hornych A; Huet de Barochez Y; Bariéty J; Branca GF; Vigeral P; Girard JF; Kazatchkine M; De Gennes JL; Truffert J; Bocquet L
    Nephron; 1987; 46(2):137-43. PubMed ID: 3600922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian rhythm of PGE2, PGF2 alpha and 6-keto-PGF1 alpha urinary excretion in healthy women.
    Ignatowska-Switalska H
    Prostaglandins Leukot Med; 1983 Jun; 11(2):233-40. PubMed ID: 6576390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of urinary prostaglandins in Bartter's syndrome.
    Zipser RD; Rude RK; Zia PK; Fichman MP
    Am J Med; 1979 Aug; 67(2):263-7. PubMed ID: 463932
    [No Abstract]   [Full Text] [Related]  

  • 25. [A fortultousness association: Bartter's syndrome and chondrocalcinosis (author's transl)].
    Goulon M; Raphael JC; De Rohan P
    Nouv Presse Med; 1980 Apr; 9(18):1291-5. PubMed ID: 7375363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced excretion of vasodilator prostaglandins in preeclampsia.
    Minuz P; Covi G; Corsato M; Probitzer P; Spiazzi L; Paluani F; Degan M; Lechi C; Lechi A
    Agents Actions Suppl; 1987; 22():175-81. PubMed ID: 3324706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal prostaglandinuria E2 in Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome.
    Lüthy C; Bettinelli A; Iselin S; Metta MG; Basilico E; Oetliker OH; Bianchetti MG
    Am J Kidney Dis; 1995 Jun; 25(6):824-8. PubMed ID: 7771477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome).
    Rimola A; Ginés P; Arroyo V; Camps J; Pérez-Ayuso RM; Quintero E; Gaya J; Rivera F; Rodés J
    J Hepatol; 1986; 3(1):111-7. PubMed ID: 3462243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudo-Bartter's syndrome from surreptitious diuretic intake: differential diagnosis with true Bartter's syndrome.
    Colussi G; Rombolà G; Airaghi C; De Ferrari ME; Minetti L
    Nephrol Dial Transplant; 1992; 7(9):896-901. PubMed ID: 1328936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excretion of primary prostanoids and their metabolites during acute volume expansion.
    Seyberth HW; Tulassay T; Kühl PG; Soeding K; Rascher W; Schweer H
    Prostaglandins; 1988 Feb; 35(2):221-32. PubMed ID: 3163156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low urinary calcium excretion in Bartter's syndrome.
    Rudin A; Aurell M; Wilske J
    Scand J Urol Nephrol; 1988; 22(1):35-9. PubMed ID: 3387909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
    JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation and diurnal variation of prostaglandin E2 6-keto-prostaglandin-F1-alpha, and thromboxane B2 excretion in healthy females.
    Rubin PD; Murthy VS; Hansen RG; Pietrowiak C
    Prostaglandins Leukot Med; 1987 May; 27(2-3):105-17. PubMed ID: 3475722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandins and aspirin therapy in Bartter's syndrome.
    Norby L; Flamenbaum W; Lentz R; Ramwell P
    Lancet; 1976 Sep; 2(7986):604-6. PubMed ID: 61344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Free dopamine excretion in disorders with increased prostaglandin synthesis.
    Güllner HG
    Prostaglandins Leukot Med; 1982 Jun; 8(6):545-51. PubMed ID: 6955810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary excretion of arterial blood prostaglandins and thromboxanes in man.
    Zipser RD; Martin K
    Am J Physiol; 1982 Mar; 242(3):E171-7. PubMed ID: 6950668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative and qualitative estimation of urinary kallikrein in a patient with Bartter's syndrome.
    Yamada K; Watanabe M; Nishikawa T; Mikami K; Shirai K; Tamura Y; Yamamoto M; Kumagai A; Matsuda Y; Moriya H
    Endocrinol Jpn; 1978 Dec; 25(6):583-9. PubMed ID: 751804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bartter's syndrome. Primary renal hyperprostaglandinism].
    Smiley JW; Del Guercio ET; March NM; Hornych A
    J Urol Nephrol (Paris); 1977 Sep; 83(9):693-9. PubMed ID: 926231
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syncrome.
    Gill JR; Bartter FC
    Am J Med; 1978 Nov; 65(5):766-72. PubMed ID: 360836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.